25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients

被引:12
|
作者
Nguyen, Nguyen N. [1 ]
Raju, Muppala N. P. [1 ]
da Graca, Briget [2 ]
Wang, Dapeng [1 ]
Mohamed, Nada A. [1 ]
Mutnal, Manohar B. [1 ]
Rao, Arundhati [1 ]
Bennett, Monica [2 ]
Gokingco, Matthew [1 ]
Huy Pham [1 ]
Mohammad, Amin A. [1 ]
机构
[1] Baylor Scott & White Cent Texas, Dept Pathol, Temple, TX 76508 USA
[2] Baylor Scott & White Res Inst, Dallas, TX USA
来源
PLOS ONE | 2022年 / 17卷 / 05期
关键词
VITAMIN-D; HEALTH;
D O I
10.1371/journal.pone.0268038
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives Studies investigating the association between vitamin D and severity of COVID-19 have mixed results perhaps due to immunoassay assessment of total 25-hydroxyvitamin D (tD) (the sum of 25-hydroxyvitamin-D2 [25-OH-D2] and 25-hydroxyvitamin-D3 [25-OH-D3]). Liquid chromatography tandem mass spectrometry (LC-MS/MS) has high analytical specificity and sensitivity for 25-OH-D2 and 25-OH-D3, and thus enables a more accurate assessment of impact on COVID-19 outcomes. Methods We established reference intervals for 25-OH-D3 and tD using LC-MS/MS. 25-OH-D2, 25-OH-D3 and tD were quantitated for 88 COVID-19 positive and 122 COVID-19 negative specimens. Chi-square or Fisher's exact tests were used to test associations in binary variables. T-Tests or Wilcoxon rank sum tests were used for continuous variables. Cox proportional hazards were used to test associations between 25-OH-D3 or tD levels and length of stay (LOS). For mortality and ventilation, logistic regression models were used. Results COVID-19 patients with deficient (<20 ng/mL) levels of 25-OH-D3 had significantly longer LOS by 15.3 days. COVID-19 P patients with deficient (<20 ng/mL) and insufficient (<30 ng/mL) of tD had significantly longer LOS by 12.1 and 8.2 days, respectively. Patients with insufficient levels of tD had significantly longer LOS by 13.7 days. COVID-19 patients with deficient serum 25-OH-D3 levels had significantly increased risk-adjusted odds of in-hospital mortality (OR [95% CI]: 5.29 [1.53-18.24]); those with insufficient 25-OH-D3 had significantly increased risk for requiring ventilation during hospitalization was found at LCMS insufficient cutoff (OR [95% CI]: 2.75 [1.10-6.90]). Conclusions There is an inverse relationship of 25-hydroxyvitamin D levels and hospital LOS for COVID-19 patients. Vitamin D status is a predictor for severity of outcomes. LCMS results are useful for assessing the odds of mortality and the need for ventilation during hospitalization.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] COVID-19 Severity Index ( SI): is it a sensitive predictor score for disease outcome in hospitalized patients?
    Gashynova, K.
    Rudakova, V.
    Rodionova, V.
    But, N.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [42] Prevalence and severity of malnutrition in hospitalized COVID-19 patients
    Bedock, Dorothee
    Lassen, Pierre Bel
    Mathian, Alexis
    Moreau, Pauline
    Couffignal, Julie
    Ciangura, Cecile
    Poitou-Bernert, Christine
    Jeannin, Anne-Caroline
    Mosbah, Helena
    Fadlallah, Jehane
    Amoura, Zahir
    Oppert, Jean-Michel
    Faucher, Pauline
    CLINICAL NUTRITION ESPEN, 2020, 40 : 214 - 219
  • [43] Severity Profile of COVID-19 in Hospitalized Pediatric Patients
    da Costa, Vania Chagas
    Montarroyos, Ulisses Ramos
    Lopes, Katiuscia Araujo de Miranda
    dos Santos, Ana Celia Oliveira
    CHILDREN-BASEL, 2024, 11 (10):
  • [44] The AIFELL Score as a Predictor of Coronavirus Disease 2019 (COVID-19) Severity and Progression in Hospitalized Patients
    Levenfus, Ian
    Ullmann, Enrico
    Petrowski, Katja
    Rose, Jutta
    Huber, Lars C.
    Stuessi-Helbling, Melina
    Schuurmans, Mace M.
    DIAGNOSTICS, 2022, 12 (03)
  • [45] Severity of Myocardial Injury in COVID-19 Hospitalized Patients
    Sanghvi, Saagar K.
    Schwarzman, Logan
    Nazir, Noreen
    Konda, Sreenivas
    CIRCULATION, 2020, 142
  • [46] ADMISSION BICARBONATE AS A PREDICTOR OF SEVERITY IN COVID-19 PATIENTS
    Molina, Paloma
    Ghaoui, Sammy
    Bazbaz, Adela
    Flores, Romina
    Varon, Joseph
    CHEST, 2024, 166 (04) : 120A - 120A
  • [47] The relationship between low maternal serum 25-hydroxyvitamin D levels and gestational diabetes mellitus according to the severity of 25-hydroxyvitamin D deficiency
    Zuhur, Sayid Shafi
    Erol, Rumeysa Selvinaz
    Kuzu, Idris
    Altuntas, Yuksel
    CLINICS, 2013, 68 (05) : 658 - 664
  • [48] Vitamin D as a predictor of negative outcomes in hospitalized COVID-19 patients: An observational study
    Bogomaz, Volodymyr
    Shatylo, Sofiia
    CANADIAN JOURNAL OF RESPIRATORY THERAPY, 2023, 59 (01): : 183 - 189
  • [49] Serum 25-Hydroxyvitamin D: A Predictor of Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes
    Herrmann, Markus
    Sullivan, David R.
    Veillard, Anne-Sophie
    McCorquodale, Thomas
    Straub, Isabella R.
    Scott, Russell
    Laakso, Markku
    Topliss, Duncan
    Jenkins, Alicia J.
    Blankenberg, Stefan
    Burton, Anthony
    Keech, Anthony C.
    DIABETES CARE, 2015, 38 (03) : 521 - 528
  • [50] Circulating 25-hydroxyvitamin D, nasopharyngeal airway metabolome, and bronchiolitis severity
    Hasegawa, K.
    Stewart, C. J.
    Celedon, J. C.
    Mansbach, J. M.
    Tierney, C.
    Camargo, C. A., Jr.
    ALLERGY, 2018, 73 (05) : 1135 - 1140